zileuton has been researched along with Neoplasms in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, X; Fan, W; Huang, C; Jacobson, O; Kang, F; Li, L; Ma, Y; Mu, Q; Tang, L; Wang, M; Wang, Z; Yang, W; Yu, Z; Zhou, Z | 1 |
| Kast, RE | 1 |
2 other study(ies) available for zileuton and Neoplasms
| Article | Year |
|---|---|
Targeting Neutrophils for Enhanced Cancer Theranostics.
Topics: Cell Line, Tumor; Drug Design; Drug Liberation; Humans; Hydroxyurea; Molecular Targeted Therapy; Nanoparticles; Neoplasms; Neutrophils; Photosensitizing Agents; Serotonin; Tumor Microenvironment | 2020 |
Tenofovir, COX inhibitors and zileuton during cancer immunotherapies: up-regulated TNF-alpha increases antigen driven lymphocyte proliferation.
Topics: Adenine; Adenylyl Cyclases; Anti-HIV Agents; Cell Division; Cyclooxygenase Inhibitors; Humans; Hydroxyurea; Immunotherapy; Lipoxygenase Inhibitors; Lymphocytes; Neoplasms; Organophosphonates; Organophosphorus Compounds; Tenofovir; Tumor Necrosis Factor-alpha; Up-Regulation | 2003 |